Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01967511 · ClinicalTrials.gov registry record

Defining the Basis of Fibromuscular Dysplasia (FMD)

A clinical trial of Spontaneous Coronary Artery Dissection and Cervical Artery Dissection, sponsored by Icahn School of Medicine at Mount Sinai.

Recruiting
Registry status
600
Enrollment target
1
Study location

NCT01967511 is a study of Spontaneous Coronary Artery Dissection and Cervical Artery Dissection that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 600 participants, below the 768-participant average among 5 other Spontaneous Coronary Artery Dissection trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01967511, a study of Spontaneous Coronary Artery Dissection and Cervical Artery Dissection, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.

RECRUITING
Registry status
600 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study has evolved and expanded since its inception. Originally the intent was to establish the functional, molecular and genetic profile of fibroblasts from Fibromuscular Dysplasia (FMD) patients as compared to carefully matched control subjects. While this remains among the objectives, the study has been expanded to undertake a fully powered cross-tissue systems genetics analysis of FMD, and now also the related arteriopathies spontaneous coronary artery dissection (SCAD) and cervical artery dissection (CvAD). The overall objective is to disclose the core biologic mechanisms of these disorders.

Study Locations (1)

New York

  • Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2013-10
Est. Completion 2030-12

What the Registry Record Tells You About NCT01967511

The ClinicalTrials.gov registry entry for NCT01967511 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 768-participant average among 5 other Spontaneous Coronary Artery Dissection trials with a reported enrollment target (22% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Spontaneous Coronary Artery Dissection appearing as the primary indexed condition, and to 0 interventions.

NCT01967511 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01967511 about?

NCT01967511 is a clinical study titled "Defining the Basis of Fibromuscular Dysplasia (FMD)". The purpose of this study has evolved and expanded since its inception. Originally the intent was to establish the functional, molecular and genetic profile of fibroblasts from Fibromuscular Dysplasia (FMD) patients as compared to carefully matched control subjects. While this remains among the obje...

What is the current status of trial NCT01967511?

This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2013-10. Estimated completion is 2030-12.

What conditions does trial NCT01967511 study?

This clinical trial studies the following conditions: Spontaneous Coronary Artery Dissection, Cervical Artery Dissection, Fibromuscular Dysplasia.

Who is sponsoring clinical trial NCT01967511?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01967511 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spontaneous Coronary Artery Dissection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.